Uta Francke, MD, Stanford University

Dr. Francke is currently a professor of genetics and pediatrics and an Investigator of the Howard Hughes Medical Institute at the Stanford University School of Medicine, director of the American Boards of Medical Genetics accredited Interdepartmental Training Program, and co-director of the UCSF/Stanford Medical Genetics Residency. She teaches human genetics to medical and graduate students and serves as a medical genetics consultant to the clinic. Dr. Francke is also currently the immediate past-president of the American Society for Human Genetics, and prior to joining Stanford was a faculty member in pediatrics and human genetics at UCSD and Yale.

Dr. Francke's research over 25 years has ranged from human to mouse chromosome identification and gene mapping to the discovery of genes involved in heritable disorders, studies of their functions and of disease-causing mechanisms. In 1994, her laboratory discovered the gene for the inherited immunodeficiency disease Wiskott-Aldrich syndrome and she was also a co-discovered of the gene for Rett syndrome. She made significant research contributions to the genotype/phenotype correlation in Marfan syndrome and related connective tissue disorders and to the molecular basis of imprinting disorders, such as Prader-Willi syndrome.

Dr. Francke has served on numerous scientific review and professional advisory committees. She is a founding member of the American College of Medical Genetics, and has been elected to membershp in the Institute of Medicine, the American Association for Advancement of Science, and the American Academy of Arts and Sciences.

Dr. Francke went to medical school in Germany, her native country, and then trained in pediatrics at the Children's Hospital of Los Angeles and in medical genetics at UCAS and UCSD. Dr. Francke advises Genetic Health on issues related to human genetics.

Geoffrey Duyk, MD, PhD, Chief Scientific Officer, Exelixis, Inc.

Dr. Duyk joined Exelixis in April 1997 from Millennium Pharmaceuticals, where he was one of the founding scientific staff. As the vice president of genomics at Millennium, he was responsible for building and leading the informatics, automation, DNA sequencing and genotyping groups as well as the mouse and human genetics group. Prior to his tenure at Millennium, Dr. Duyk was an assistant professor of Harvard Medical School (HMS) in the Department of Genetics and assistant investigator of the Howard Hughes Medical Institute (HHMI). While at HMS, Dr. Duyk was a co-principal investigator in the National Institutes of Health (NIH) funded Cooperative Human Linkage Center. Dr. Duyk has been and continues to be a member of numerous of NIH panels and oversight committees focused on the planning and execution of the human genome project. Dr. Duyk holds a PhD and MD from Case Western Research University and following the completion of his medical and fellowship training at University of California, San Francisco, was the only person to have been awarded both a Markey fellowship and a HHMI post-doctoral fellowship. Dr. Duyk advises Genetic Health on issues related to human genetics and genomics.

Brad Peterson, CIO & CTO, Epoch Partners, Inc.

Mr. Peterson has experience both in the online financial services industry and the convergent telecommunications industry that ranges from software development and systems integration to data center operations. At Epoch Partners Mr. Peterson and his team apply technology to improve the distribution of securities, trading, and liquidity in the equity markets and using the power of the Internet to create a new equity research destination for individual and institutional investors. Prior to Epoch Partners, Mr. Peterson was senior vice president at Schwab Technology, where he was responsible for software development and systems integration in support of Schwab's Retail Business Enterprise. Prior to joining Schwab, Mr. Peterson served as director of information technology at Pacific Bell Mobile Services and as vice president of telecommunications at First Interstate. Mr. Peterson earned a Bachelor of Science degree from University of California, Los Angeles (UCLA), and a Master of Science degree from the MIT Sloan School of Management. Mr. Peterson advises Genetic Health on issues related to information technology and software development.

Mark Carlson, COO & CFO, The Urbanite Network

Mr. Carlson is COO and CFO of the Urbanite Network which provides modular technology that enables businesses to rapidly scale their Internet presence. Prior to joining Urbanite, Mr. Carlson was general manager of the Internet Security Group at CyberMedia. Prior to joining Cybermedia, Mr. Carlson was the co-founder and CEO of Walk Softly which developed Guard Dog, an Internet privacy and security product that became a PC Data Top 10 product. Prior to Walk Softly, Mr. Carlson served as vice president of business development and CFO for Digital Pictures, where he raised three rounds of financing from Times Mirror, Acclaim, and venture capital sources. Previously, Mr. Carlson spent six years as an investment banker at Montgomery Securities and PaineWebber. Mr. Carlson holds a BS in Economics from the Wharton School at the University of Pennsylvania. Mr. Carlson advises Genetic Health on issues related to Internet and software privacy and security.

top